---
validationTarget: '_bmad-output/planning-artifacts/prd.md'
validationDate: '2026-03-10'
inputDocuments:
  - docs/index.md
  - docs/project-overview.md
  - docs/architecture.md
  - docs/data-models-main.md
  - docs/api-contracts-main.md
  - docs/component-inventory-main.md
  - docs/development-guide.md
  - docs/custom-codes-reference.md
  - _bmad-output/project-context.md
  - _bmad-output/planning-artifacts/architecture.md
validationStepsCompleted:
  - step-v-01-discovery
  - step-v-02-format-detection
  - step-v-03-density-validation
  - step-v-04-brief-coverage-validation
  - step-v-05-measurability-validation
  - step-v-06-traceability-validation
  - step-v-07-implementation-leakage-validation
  - step-v-08-domain-compliance-validation
  - step-v-09-project-type-validation
  - step-v-10-smart-validation
  - step-v-11-holistic-quality-validation
  - step-v-12-completeness-validation
  - step-v-13-report-complete
validationStatus: COMPLETE
holisticQualityRating: 4.5/5
overallStatus: Pass
---

# PRD Validation Report

**PRD Being Validated:** `_bmad-output/planning-artifacts/prd.md`
**Validation Date:** 2026-03-10

## Input Documents

| Document | Status |
|---|---|
| docs/index.md | Loaded |
| docs/project-overview.md | Loaded |
| docs/architecture.md | Loaded |
| docs/data-models-main.md | Loaded |
| docs/api-contracts-main.md | Loaded |
| docs/component-inventory-main.md | Loaded |
| docs/development-guide.md | Loaded |
| docs/custom-codes-reference.md | Loaded |
| _bmad-output/project-context.md | Loaded |
| _bmad-output/planning-artifacts/architecture.md | Loaded |

## Validation Findings

### Format Detection

**PRD Structure (all ## Level 2 headers):**
1. Executive Summary
2. Project Classification
3. Success Criteria
4. Product Scope
5. User Journeys
6. Domain-Specific Requirements
7. Innovation & Novel Patterns
8. Web Application Specific Requirements
9. Project Scoping & Phased Development
10. Functional Requirements
11. Non-Functional Requirements

**BMAD Core Sections Present:**
- Executive Summary: Present
- Success Criteria: Present
- Product Scope: Present
- User Journeys: Present
- Functional Requirements: Present
- Non-Functional Requirements: Present

**Format Classification:** BMAD Standard
**Core Sections Present:** 6/6

### Information Density Validation

**Anti-Pattern Violations:**

**Conversational Filler:** 0 occurrences

**Wordy Phrases:** 0 occurrences

**Redundant Phrases:** 0 occurrences

**Total Violations:** 0

**Severity Assessment:** Pass

**Recommendation:** PRD demonstrates good information density with minimal violations.

### Product Brief Coverage

**Status:** N/A — No Product Brief was provided as input. PRD was built directly from brownfield codebase documentation (9 technical reference documents).

### Measurability Validation

#### Functional Requirements

**Total FRs Analysed:** 58

**Format Violations:** 0

**Subjective Adjectives Found:** 0

**Vague Quantifiers Found:** 0

**Implementation Leakage:** 1
- FR48 (line 616): `"via HTMX polling"` — names specific implementation technology; brownfield-justified (consistent with Web App Requirements section tech stack naming; developer-primary audience)

**FR Violations Total:** 1

#### Non-Functional Requirements

**Total NFRs Analysed:** 23

**Missing Metrics:** 0

**Incomplete Template:** 0

**Implementation References:** 8
- NFR2 (line 682): `select_related()` / `prefetch_related()` ORM method names — brownfield Maintainability convention, developer audience
- NFR6 (line 690): "HTMX polling cycle" — brownfield tech stack reference, consistent with Web App section
- NFR7 (line 696): `` `SECURE_SSL_REDIRECT` `` — Django setting name; brownfield developer convention
- NFR8 (line 698): "CSPMiddleware" class name — brownfield convention
- NFR12 (line 706): "Django's PBKDF2+SHA256 default password hasher" — brownfield security constraint for developers
- NFR20 (line 738): `TimeStampedModel`, `UserTrackingMixin`, file paths in `ndas/custom_codes/` — intentional Maintainability convention for developers
- NFR21 (line 740): `db_index=True`, ORM method syntax — intentional Maintainability convention for developers
- NFR22 (line 742): `get_object_or_404()`, `.objects.get()` — intentional Maintainability convention for developers

**NFR Violations Total:** 8 (all brownfield-developer-justified)

#### Overall Assessment

**Total Requirements:** 81 (58 FR + 23 NFR)
**Total Violations (strict):** 9
**Brownfield-Justified Exemptions:** 9
**Net Unmitigated Violations:** 0

**Severity (strict):** Warning (9 violations, 5–10 range)
**Severity (with brownfield exemption):** Pass

**Recommendation:** All 9 implementation-reference violations are appropriate for a brownfield re-documentation PRD with a developer-primary audience documenting established framework conventions. No changes required.

### Traceability Validation

#### Chain Validation

**Executive Summary → Success Criteria:** Intact — three-phase vision maps directly to user success, business metrics, and technical baseline.

**Success Criteria → User Journeys:** Intact — all 4 user success criteria covered by Journeys 1–3; business success metrics covered by Journeys 4–5. Expected gap: Phase 3 AI metrics have no journey (Phase 3 is planned with no journeys authored, acceptable).

**User Journeys → Functional Requirements:** Intact — all 5 journeys have supporting FRs confirmed by Journey Requirements Summary table in PRD.

**Scope → FR Alignment:** Intact — all Phase 1 and Phase 2 scope items have corresponding FR coverage.

#### Orphan Elements

**Orphan Functional Requirements:** 0 (strict definition — all FRs trace to Executive Summary, Innovation, or Scoping sections)

**Partially Traced FRs (journey narrative gap, not structural orphans):**
- FR17–FR19 (Multi-clinician opinion layer): traced through Innovation section + Scoping Phase 1 list; no dedicated journey narrative shows intra-institution peer review in action
- FR27 (Bookmarks): utility convenience feature; traceable to user efficiency goals in Executive Summary; not named in any journey
- FR50–FR51 (Patient Transfer): referenced in Journey 5 scoping context; not shown in Journey 5 narrative
- FR56–FR58 (Phase 3 AI): Phase 3 is planned with no journeys authored — expected and acceptable gap

**Unsupported Success Criteria:** 0 (Phase 3 AI metrics intentionally lack journey coverage)

**User Journeys Without FRs:** 0

#### Traceability Matrix Summary

| Capability Area | Journey Source | Status |
|---|---|---|
| Patient Record Management (FR1–5) | Journey 1, Journey 3 | Fully Traced |
| Assessment Workflows (FR6–12) | Journey 1 | Fully Traced |
| Video Management (FR13–16) | Journey 1 | Fully Traced |
| Multi-Clinician Opinion (FR17–19) | Innovation + Scoping sections | Partially Traced |
| Problem List (FR20–22) | Journey 1 | Fully Traced |
| Report Generation (FR23–25) | Journey 1 | Fully Traced |
| Attachments & Bookmarks (FR26–27) | Journey 3 (FR26); Executive Summary (FR27) | Partially Traced |
| User Management (FR28–31) | Journey 4 | Fully Traced |
| Multi-Institution Foundation (FR32–37) | Journey 4, Journey 5 | Fully Traced |
| Referral System (FR38–45) | Journey 2 | Fully Traced |
| Consultation & Notifications (FR46–49) | Journey 2 | Fully Traced |
| Patient Transfer (FR50–51) | Journey 5 scoping | Partially Traced |
| Audit Trail (FR52–55) | Journey 1 (capabilities revealed) | Fully Traced |
| Phase 3 AI (FR56–58) | Innovation + Scoping sections | Expected Gap |

**Total Traceability Issues:** 0 structural broken chains; 4 partial traces (all informational)

**Severity:** Pass

**Recommendation:** Traceability chain is intact. The four partially-traced capability areas (multi-clinician opinion, bookmarks, patient transfer, Phase 3 AI) all trace to product sections — they would benefit from a future Journey enhancement if a dedicated user journey for intra-institution peer review is authored. Not blocking.

### Implementation Leakage Validation

#### Leakage by Category (FRs and NFRs only)

**Frontend Libraries (HTMX):** 2 violations
- FR48 (line 616): "via HTMX polling"
- NFR6 (line 690): "HTMX polling cycle"

**Backend Framework (Django) — models, API, settings:** 6 violations
- NFR2 (line 682): `select_related()`, `prefetch_related()` ORM methods
- NFR7 (line 696): `SECURE_SSL_REDIRECT` setting name
- NFR8 (line 698): "CSPMiddleware" class name
- NFR12 (line 706): "Django's PBKDF2+SHA256"
- NFR20 (line 738): "Django models", class names, file paths
- NFR21 (line 740): `db_index=True`, ORM method syntax
- NFR22 (line 742): `get_object_or_404()`, `.objects.get()`

**Third-party library (Video.js):** 1 violation
- NFR3 (line 684): "Video.js seek functionality"

**Total Implementation Leakage Violations (strict):** 10
**Brownfield-Justified Exemptions:** 10
**Net Unmitigated Violations:** 0

**Severity (strict):** Critical (>5 violations)
**Severity (with brownfield exemption):** Pass

**Recommendation:** All violations are appropriate for a developer-primary brownfield re-documentation PRD documenting the established technology stack. NFRs 20–22 are intentional developer coding standards. All other references name mechanisms established in the Web App Requirements technology section. If PRD is adapted for clinical or management audiences, these sections should be abstracted. Not blocking for current developer-primary scope.

### Domain Compliance Validation

**Domain:** Healthcare (Clinical / Neurodevelopmental)
**Jurisdiction:** Sri Lanka
**Complexity:** High (regulated domain)

#### Required Special Sections

| Requirement | Status | Notes |
|---|---|---|
| Clinical Requirements | Present ✅ | Domain-Specific Requirements → Clinical Decision Support Classification; Assessment Guideline Alignment |
| Regulatory Pathway | Present ✅ | Correctly handles "no formal Sri Lankan health data regulations enacted" with forward-looking architecture posture |
| Validation Methodology | Present ✅ | Innovation → Validation Approach table; Domain Requirements → guideline deviation validation requirement; Phase 3 AI clinical validation requirement |
| Safety Measures | Present ✅ | Domain Requirements → Risk Mitigations; mandatory clinician attribution; AI outputs as decision support only |
| HIPAA Compliance | N/A ✅ | Sri Lankan jurisdiction — HIPAA is US-specific; correctly excluded |
| FDA Classification | N/A ✅ | Sri Lankan jurisdiction; no FDA pathway applicable |
| Patient Consent | Present ✅ | Domain Requirements — correctly scopes consent outside application boundary |

#### Compliance Summary

**Required Sections Present:** 4/4 (plus 2 N/A correctly handled)
**Compliance Gaps:** 0

**Severity:** Pass

**Recommendation:** All healthcare domain compliance requirements are adequately addressed for the Sri Lankan clinical context. The regulatory pathway is correctly documented as forward-looking (no current enacted regulations). Jurisdiction-specific exemptions (HIPAA, FDA) are appropriately excluded. No gaps found.

### Project-Type Compliance Validation

**Project Type:** web_app

#### Required Sections

| Section | Status |
|---|---|
| browser_matrix | Present ✅ — Web App Requirements → Browser Matrix table |
| responsive_design | Present ✅ — Web App Requirements → Responsive Design section |
| performance_targets | Present ✅ — Web App Requirements → Performance Targets table |
| seo_strategy | Present ✅ — Correctly documented as N/A (all views login-protected) |
| accessibility_level | Present ✅ — Correctly documented as not required at this time |

#### Excluded Sections (Should Not Be Present)

| Section | Status |
|---|---|
| native_features | Absent ✅ — "No native app" explicitly stated |
| cli_commands | Absent ✅ — No CLI sections |

#### Compliance Summary

**Required Sections:** 5/5 present
**Excluded Sections Present:** 0 violations
**Compliance Score:** 100%

**Severity:** Pass

**Recommendation:** All required web_app sections are present and adequately documented. No excluded sections found.

### SMART Requirements Validation

**Total Functional Requirements:** 58

#### Scoring Summary

**All scores ≥ 3:** 97% (56/58)
**All scores ≥ 4:** 86% (~50/58)
**Overall Average Score:** ~4.5/5.0

#### Flagged FRs (score < 3 in any category)

| FR | Specific | Measurable | Attainable | Relevant | Traceable | Avg | Flag Reason |
|---|---|---|---|---|---|---|---|
| FR27 (Bookmarks) | 3 | 3 | 5 | 4 | 2 | 3.4 | T=2: No journey narrative; "quick navigation" lacks metric |
| FR56 (AI GMA identification) | 3 | 2 | 3 | 5 | 5 | 3.6 | M=2: Phase 3 planned — no accuracy targets defined |
| FR57 (AI clinical suggestions) | 3 | 2 | 3 | 5 | 4 | 3.4 | M=2: Phase 3 planned — no accuracy/threshold criteria |

#### Borderline FRs (scores exactly 3, not flagged)

| FR | Specific | Measurable | Notes |
|---|---|---|---|
| FR7–FR10 (Assessment types) | 3 | 3 | "All structured X fields" — relies on domain knowledge for test completeness |
| FR22 (Problem list view) | 3 | 3 | "Complete/full" is implicit but testable |

#### Improvement Suggestions

**FR27:** Strengthen traceability by linking to a user efficiency goal; replace "quick navigation" with a specific metric (e.g., "bookmarked patient accessible within 2 clicks from the main navigation").

**FR56–FR57:** Measurability intentionally deferred — Phase 3 accuracy metrics require clinical validation design. Acceptable for a "planned" scope PRD. Future Phase 3 PRD iteration must add: accuracy benchmarks vs. expert baseline, sensitivity/specificity targets, and minimum training dataset size criteria.

#### Overall Assessment

**Flagged FRs:** 3/58 = 5.2%

**Severity:** Pass (<10% flagged)

**Recommendation:** Functional Requirements demonstrate strong SMART quality overall. FR27 traceability gap is informational. FR56–FR57 measurability deferral is appropriate for planned Phase 3 scope and does not affect Phase 1 or Phase 2 implementation.

### Holistic Quality Assessment

#### Document Flow & Coherence

**Assessment:** Good

**Strengths:**
- Logical narrative arc: problem context → success → user journeys → constraints → differentiators → technology → roadmap → capability contract → quality contract
- Each section flows from the previous; Journey Requirements Summary table bridges journeys to FRs effectively
- Phase 1/2/3 progression is consistent throughout all sections

**Areas for Improvement:**
- Transition from Domain Requirements to Innovation to Web App Specifics has minor discontinuity (follows BMAD template order — acceptable)
- No Journey narrative for multi-clinician peer review (a Phase 1 implemented feature)

#### Dual Audience Effectiveness

**For Humans:**
- Executive-friendly: Strong — Executive Summary and "What Makes This Special" are scan-readable
- Developer clarity: Strong — specific FRs, named conventions in NFRs, full technology context
- Clinical stakeholder clarity: Good — 5 journey narratives are accessible to non-technical readers
- Stakeholder decision-making: Good — phase status, scope, out-of-scope table, success metrics all clear

**For LLMs:**
- Machine-readable structure: Strong — consistent ## headers, FR/NFR numbering, summary tables
- UX readiness: Good — "Capabilities revealed" in each journey maps to interaction flows
- Architecture readiness: Strong — NFRs name technology constraints; Web App, Data Integrity, and Maintainability sections give full architecture context
- Epic/Story readiness: Strong — 58 FRs in 14 capability areas with phase labels = direct epic-level mapping

**Dual Audience Score:** 4.5/5

#### BMAD PRD Principles Compliance

| Principle | Status | Notes |
|---|---|---|
| Information Density | Met ✅ | 0 anti-pattern violations |
| Measurability | Met ✅ | 97% FRs SMART-pass; Phase 3 measurability deferred appropriately |
| Traceability | Met ✅ | 0 broken chains; 4 partial traces (all informational) |
| Domain Awareness | Met ✅ | Healthcare + Sri Lanka jurisdiction; 4/4 required sections present |
| Zero Anti-Patterns | Met ✅ | 0 filler violations in density scan |
| Dual Audience | Met ✅ | Strong human readability + LLM-optimised structure |
| Markdown Format | Met ✅ | ## Level 2 headers throughout, tables, consistent formatting |

**Principles Met:** 7/7

#### Overall Quality Rating

**Rating:** 4.5/5 — Good to Excellent

#### Top 3 Improvements

1. **Add a Phase 3 AI interaction journey sketch** — FR56–FR58 would close their partial-trace status with even a brief Journey 6 showing a clinician receiving an AI-assisted movement type suggestion during GMA assessment. Not blocking; valuable for Phase 3 planning.

2. **Add a multi-clinician peer review journey segment** — FR17–FR19 (intra-institution opinion layer) are Phase 1 implemented features with no journey narrative. An extension to Journey 1 or a dedicated segment would close the partial-trace status for these FRs.

3. **Strengthen FR27 (Bookmarks)** — Replace "quick navigation" with a specific metric; link to a user efficiency objective. Closes the one remaining SMART flag.

#### Summary

**This PRD is:** A comprehensive, well-structured brownfield re-documentation PRD covering a complex healthcare system across three phases, with strong traceability, measurability, and dual-audience effectiveness — ready for downstream architecture and epic breakdown work.

**To make it great:** Add a short Phase 3 journey sketch and a multi-clinician peer review journey segment to close the remaining partial-trace gaps.

### Completeness Validation

#### Template Completeness

**Template Variables Found:** 0 — No template variables remaining ✓

(Note: `{{ request.csp_nonce }}` on line 368 is Django template syntax within a prose example — not a PRD placeholder)

#### Content Completeness by Section

| Section | Status |
|---|---|
| Executive Summary | Complete ✅ |
| Project Classification | Complete ✅ |
| Success Criteria | Complete ✅ |
| Product Scope | Complete ✅ |
| User Journeys | Complete ✅ — 5 journeys + Requirements Summary table |
| Domain-Specific Requirements | Complete ✅ |
| Innovation & Novel Patterns | Complete ✅ |
| Web Application Specific Requirements | Complete ✅ |
| Project Scoping & Phased Development | Complete ✅ |
| Functional Requirements | Complete ✅ — 58 FRs across 14 capability areas |
| Non-Functional Requirements | Complete ✅ — 23 NFRs across 7 categories |

#### Section-Specific Completeness

**Success Criteria Measurability:** All measurable — specific metrics, targets, and baselines present
**User Journeys Coverage:** Complete — covers clinical staff, clinician, institution admin, superadmin (5 personas / 5 journeys)
**FRs Cover MVP Scope:** Yes — all Phase 1 and Phase 2 scope items have FR coverage
**NFRs Have Specific Criteria:** All 23 NFRs have specific, measurable criteria

#### Frontmatter Completeness

**stepsCompleted:** Present ✅ (11 creation steps)
**classification:** Present ✅ (domain, projectType, complexity, context, scope, audience)
**inputDocuments:** Present ✅ (9 documents tracked)
**date:** Present ✅ (2026-03-09)

**Frontmatter Completeness:** 4/4

#### Completeness Summary

**Overall Completeness:** 100% (11/11 sections complete)

**Critical Gaps:** 0
**Minor Gaps:** 0

**Severity:** Pass

**Recommendation:** PRD is complete with all required sections and content present. Ready for downstream work.
